Condition
Moderate-to-Severe Asthma
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07191535Phase 2Not Yet Recruiting
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)
NCT06422663CompletedPrimary
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
NCT01603277Phase 2CompletedPrimary
Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids
Showing all 3 trials